← Evidence map

ArticleThe Lancet. Global health2022

Fluvoxamine for the treatment of COVID-19.

Michael G Dodds et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2022
2023
2024
2025
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35180412